Cognizant Tech Solutions Is Maintained at Equal-Weight by Barclays
Cognizant Tech Solutions Is Maintained at Equal-Weight by Barclays
Barclays: Maintaining the Cognizant Tech Solns (CTSH.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $80.00 to $75.00.
Barclays: Maintaining the Cognizant Tech Solns (CTSH.US) rating, adjusted from a shareholding wait-and-see rating to a shareholding wait-and-see rating, and the target price was adjusted from $80.00 to $75.00.
Barclays Maintains Equal-Weight on Cognizant Tech Solns, Lowers Price Target to $75
Barclays analyst Ramsey El-Assal maintains Cognizant Tech Solns with a Equal-Weight and lowers the price target from $80 to $75.
Cognizant Technology Solutions (NASDAQ:CTSH) Has More To Do To Multiply In Value Going Forward
Barclays Reaffirms Their Hold Rating on Cognizant (CTSH)
Cognizant's Bluebolt Program Delivers More Than $150M in Estimated Annualized Cost Savings for Enterprises
Cognizant associates have submitted more than 130K ideas via Bluebolt, a grassroots innovation program launched a year ago; more than 23K ideas have been implemented with clients More than 220K assoc
Congruent Solutions Appoints Mahesh Natarajan as Chief Revenue Officer
Unveiling 7 Analyst Insights On Cognizant Tech Solns
Analysts' ratings for Cognizant Tech Solns (NASDAQ:CTSH) over the last quarter vary from bullish to bearish, as provided by 7 analysts.The table below provides a snapshot of their recent ratings, show
Goldman's Buybacks Basket: Buyback Growth Will Be 13% in 2024
Goldman Sachs analysts rebalanced their “buybacks basket” as 2024 buyback growth is forecasted to be 13%.
Cognizant Tech Solutions Is Maintained at Buy by Citigroup
Cognizant Tech Solutions Is Maintained at Buy by Citigroup
Citibank: Maintains the Cognizant Tech Solns (CTSH.US) rating, adjusted from buy to buy rating, and adjusted the target price from $90.00 to $82.00.
Citibank: Maintains the Cognizant Tech Solns (CTSH.US) rating, adjusted from buy to buy rating, and adjusted the target price from $90.00 to $82.00.
Citigroup Maintains Buy on Cognizant Tech Solns, Lowers Price Target to $82
Citigroup analyst Ashwin Shirvaikar maintains Cognizant Tech Solns with a Buy and lowers the price target from $90 to $82.
Cognizant Tech Solns Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/22/2024 20.94% Citigroup $90 → $82 Maintains Buy 04/01/2024 17.99% Susquehanna $87 → $80 Downgrades Pos
Cognizant Technology Partners With Microsoft to Deploy AI Chatbot Copilot
Cognizant Technology Solutions (CTSH) said Monday that it is collaborating with Microsoft (MSFT) in a project to expand the use of generative AI in enterprise business operations using the software gi
Cognizant and Microsoft Announce Global Partnership to Expand Adoption of Generative Ai in the Enterprise, and Drive Industry Transformation
Cognizant (NASDAQ:CTSH) and Microsoft Corp. announced an expanded partnership with the goal of making Microsoft's generative AI and Copilots available to millions of users, to transform enterprise bus
Top 10 Most Oversold S&P 500 Stocks
Is Cognizant Technology Solutions (NASDAQ:CTSH) A Risky Investment?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe
Correction: --Morgan Stanley Trims Cognizant Technology Solutions' Price Target to $64 From $65, Keeps Equalweight Rating
(Corrected with correct price target and rating in the headline.)
Jack Daniels Parent Company, EA, Cognizant Among 6 Stocks That Shine When Nvidia Slips: Analysis
Six S&P 500 stocks often experience a surge when shares of Nvidia Corporation (NASDAQ:NVDA) take a dip, an analysis by CNBC revealed.What Happened: The six U.S.-listed stocks that typically see a rise
Cognizant Technology Solutions Corporation's (NASDAQ:CTSH) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
No Data